Publication | Closed Access

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Checkmate 037MedicineMelanomaNivolumab Versus ChemotherapyImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyAdvanced MelanomaMolecular OncologyRadiologyHealth Sciences